Bli medlem
Bli medlem

Du är här


Episurf Medical AB: Redeye: Episurf Medical - High activity under the (re-)surface

In view of Episurf Medical's robust clinical pipeline, continuously
increased user base in Europe, and potential regulatory progress
towards the US market, we see scope for high operational activity in
2020. But reversing 2019's poor share performance hinges on putting
sustainable funding in place that is better aligned with the
long-term strategy. Our estimates and fair values are updated, and we
also discuss our expectations on the ankle implant.

Read more and download the research update:

Start following companies at Redeye to receive the latest equity
research within Life Science and Technology.

This is a press release from Redeye - Research Powered Investment


Författare Cision News

Tala om vad ni tycker

Tala om vad ni tycker

Ni är just nu inne på en betaversion av nya aktiespararna. Lämna gärna feedback på vad ni tycker i formuläret nedan.